Fig. 2From: Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney diseaseAntibody response following vaccination with the second dose of coronavirus disease 2019 (COVID-19) vaccine in hemodialysis patients. The median antibody titer decreased from 185.5 [95.1–323.5] U/mL 1 month after the second vaccination to 97.4 [62.5–205.5] U/mL 6 months after the second vaccination (p < 0.05)Back to article page